Evidence map›Paper›PMID 29888960›Full record

ArticleThe British journal of radiology2018

Gene expression profiling of breast cancer cell lines treated with proton and electron radiations.

Valentina Bravatà, Luigi Minafra, Francesco Paolo Cammarata, Pietro Pisciotta, Debora Lamia, Valentina Marchese, Giada Petringa, Lorenzo Manti, Giuseppe Ap Cirrone, Maria Carla Gilardi and 3 more

Abstract read
In one paragraph

Article in The British journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Valentina Bravatà1 Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR) , Cefalù , Italy.
Luigi Minafra1 Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR) , Cefalù , Italy.
Francesco Paolo Cammarata1 Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR) , Cefalù , Italy.
Pietro Pisciotta1 Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR) , Cefalù , Italy.
Debora Lamia1 Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR) , Cefalù , Italy.
Valentina Marchese2 National Institute for Nuclear Physics, Laboratori Nazionali del Sud, INFN-LNS , Catania , Italy.
Giada Petringa2 National Institute for Nuclear Physics, Laboratori Nazionali del Sud, INFN-LNS , Catania , Italy.
Lorenzo Manti4 Department of Physics, University of Naples Federico II, via Cintia, I-80126 Naples , Italy.
Giuseppe Ap Cirrone2 National Institute for Nuclear Physics, Laboratori Nazionali del Sud, INFN-LNS , Catania , Italy.
Maria Carla Gilardi1 Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR) , Cefalù , Italy.
Giacomo Cuttone2 National Institute for Nuclear Physics, Laboratori Nazionali del Sud, INFN-LNS , Catania , Italy.
Giusi Irma Forte1 Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR) , Cefalù , Italy.
Giorgio Russo1 Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR) , Cefalù , Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTechnological advances in radiation therapy are evolving with the use of hadrons, such as protons, indicated for tumors where conventional radiotherapy does not give significant advantages or for tumors located in sensitive regions, which need the maximum of dose-saving of the surrounding healthy tissues. The genomic response to conventional and non-conventional linear energy transfer exposure is a poor investigated topic and became an issue of radiobiological interest. The aim of this work was to analyze and compare molecular responses in term of gene expression profiles, induced by electron and proton irradiation in breast cancer cell lines.

methodsWe studied the gene expression profiling differences by cDNA microarray activated in response to electron and proton irradiation with different linear energy transfer values, among three breast cell lines (the tumorigenic MCF7 and MDA-MB-231 and the non-tumorigenic MCF10A), exposed to the same sublethal dose of 9 Gy.

resultsGene expression profiling pathway analyses showed the activation of different signaling and molecular networks in a cell line and radiation type-dependent manner. MCF10A and MDA-MB-231 cell lines were found to induce factors and pathways involved in the immunological process control.

conclusionHere, we describe in a detailed way the gene expression profiling and pathways activated after electron and proton irradiation in breast cancer cells. Summarizing, although specific pathways are activated in a radiation type-dependent manner, each cell line activates overall similar molecular networks in response to both these two types of ionizing radiation. Advances in knowledge: In the era of personalized medicine and breast cancer target-directed intervention, we trust that this study could drive radiation therapy towards personalized treatments, evaluating possible combined treatments, based on the molecular characterization.

Indexed as

Gene Expression ProfilingProton TherapyAdenocarcinomaBreast NeoplasmsCarcinoma, Ductal, BreastCell LineCell Line, TumorElectronsGene ExpressionHumansLinear Energy TransferOligonucleotide Array Sequence AnalysisPrecision MedicineProtonsRadiation ToleranceProtons

Identifiers

PMID29888960
PMCPMC6223146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.